Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.
暂无分享,去创建一个
U. Suter | L. Parada | L. Le | Zhiguo Chen | T. Shipman | Chiachi Liu
[1] Jiaoti Huang,et al. Identification of a Cell of Origin for Human Prostate Cancer , 2010, Science.
[2] B. Tysnes,et al. Tumor-initiating and -propagating cells: cells that we would like to identify and control. , 2010, Neoplasia.
[3] Rosalie E Ferner. Neurofibromatosis 1 , 2010, European Journal of Human Genetics.
[4] E. Fabbri,et al. Pseudoxanthoma-elasticum-like syndrome and thalassemia: an update. , 2009, Dermatology online journal.
[5] D. Burns,et al. Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas. , 2009, Cell stem cell.
[6] E. Rallis,et al. Giant plexiform neurofibroma in a patient with neurofibromatosis type I. , 2009, Dermatology online journal.
[7] Hans Clevers,et al. Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.
[8] Arturo Alvarez-Buylla,et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. , 2009, Cancer cell.
[9] P. Nelson,et al. Retentive Multipotency of Adult Dorsal Root Ganglia Stem Cells , 2009, Cell transplantation.
[10] N. Ratner,et al. How does the Schwann cell lineage form tumors in NF1? , 2008, Glia.
[11] L. Sommer,et al. Development of the Schwann cell lineage: From the neural crest to the myelinated nerve , 2008, Glia.
[12] G. Hutchins,et al. Nf1-Dependent Tumors Require a Microenvironment Containing Nf1 +/−- and c-kit-Dependent Bone Marrow , 2008, Cell.
[13] S. Morrison,et al. The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. , 2008, Cancer cell.
[14] A. Stemmer-Rachamimov,et al. Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells. , 2008, Cancer cell.
[15] D. Burns,et al. Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation. , 2008, Cancer cell.
[16] P. Sheard,et al. Developmental loss of NT‐3 in vivo results in reduced levels of myelin‐specific proteins, a reduced extent of myelination and increased apoptosis of Schwann cells , 2008, Glia.
[17] Xin-Fu Zhou,et al. Isolation and Characterization of Neural Crest Progenitors from Adult Dorsal Root Ganglia , 2007, Stem cells.
[18] L. Parada,et al. Tumor microenvironment and neurofibromatosis type I: connecting the GAPs , 2007, Oncogene.
[19] D. Evans,et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 , 2006, Journal of Medical Genetics.
[20] D. Kaplan,et al. Analysis of the neurogenic potential of multipotent skin-derived precursors , 2006, Experimental Neurology.
[21] AB Trovó‐Marqui,et al. Neurofibromin: a general outlook , 2006, Clinical genetics.
[22] Jeff Biernaskie,et al. Skin-Derived Precursors Generate Myelinating Schwann Cells for the Injured and Dysmyelinated Nervous System , 2006, The Journal of Neuroscience.
[23] U. Suter,et al. ErbB2 Signaling in Schwann Cells Is Mostly Dispensable for Maintenance of Myelinated Peripheral Nerves and Proliferation of Adult Schwann Cells after Injury , 2006, The Journal of Neuroscience.
[24] R. Mirsky,et al. The origin and development of glial cells in peripheral nerves , 2005, Nature Reviews Neuroscience.
[25] F. Miller,et al. Isolation and Characterization of Multipotent Skin‐Derived Precursors from Human Skin , 2005, Stem cells.
[26] D. Gutmann,et al. Neurofibromatosis 1: from lab bench to clinic. , 2005, Pediatric neurology.
[27] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[28] Philipp Berger,et al. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells , 2003, Molecular and Cellular Neuroscience.
[29] D. Burns,et al. Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment , 2002, Science.
[30] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[31] A. Sadikot,et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin , 2001, Nature Cell Biology.
[32] L. Parada,et al. Neurofibromin, a tumor suppressor in the nervous system. , 2001, Experimental cell research.
[33] T. Jacks,et al. NF1 Tumor Suppressor Gene Function Narrowing the GAP , 2001, Cell.
[34] G. Tennekoon,et al. Neurofibromatosis type 1 I. General overview , 2000, Journal of neuroscience research.
[35] V. Riccardi,et al. Associations of clinical features in neurofibromatosis 1 (NF1) , 2000, Genetic epidemiology.
[36] Karlyne M. Reilly,et al. Mouse models of tumor development in neurofibromatosis type 1. , 1999, Science.
[37] S. Velasco-Miguel,et al. Mouse tumor model for neurofibromatosis type 1. , 1999, Science.
[38] U. Suter,et al. P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors. , 1999, Development.
[39] David J. Anderson,et al. Prospective Identification, Isolation by Flow Cytometry, and In Vivo Self-Renewal of Multipotent Mammalian Neural Crest Stem Cells , 1999, Cell.
[40] J. Dick,et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.
[41] H. Armah. Malignant Astrocytomas Originate from Neural Stem/Progenitor Cells in a Somatic Tumor Suppressor Mouse Model , 2010 .
[42] R. Feil,et al. Inducible Cre mice. , 2009, Methods in molecular biology.
[43] Philippe Soriano. Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.
[44] B. R. Korf,et al. Plexiform neurofibromas. , 1999, American journal of medical genetics.
[45] E. B. Prophet,et al. Laboratory methods in histotechnology , 1992 .